Duracrin Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$1M
- Investors
-
1
Duracrin General Information
Description
The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- 115 Munson Street
- 6TH FLOOR
- New Haven, CT 06511
- United States
+1 (860)
Primary Industry
Biotechnology
Corporate Office
- 115 Munson Street
- 6TH FLOOR
- New Haven, CT 06511
- United States
+1 (860)
Duracrin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 16-Feb-2026 | $1M | Completed | Stealth |
Duracrin Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yale Ventures | Accelerator/Incubator |
Duracrin FAQs
-
When was Duracrin founded?
Duracrin was founded in 2025.
-
Where is Duracrin headquartered?
Duracrin is headquartered in New Haven, CT.
-
What industry is Duracrin in?
Duracrin’s primary industry is Biotechnology.
-
Is Duracrin a private or public company?
Duracrin is a Private company.
-
What is Duracrin’s current revenue?
The current revenue for Duracrin is .
-
How much funding has Duracrin raised over time?
Duracrin has raised $1M.
-
Who are Duracrin’s investors?
Yale Ventures has invested in Duracrin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
